matrix metallopeptidase 2
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The MMP2 gene provides instructions for making an enzyme called matrix metallopeptidase 2. This enzyme is produced in cells throughout the body and becomes part of the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells. One of the major known functions of matrix metallopeptidase 2 is to cut (cleave) a protein called type IV collagen. Type IV collagen is a major structural component of basement membranes, which are thin, sheet-like structures that separate and support cells as part of the extracellular matrix.
Video picks for GenesVideo library
Normal function
The MMP2 gene provides instructions for making an enzyme called matrix metallopeptidase 2. This enzyme is produced in cells throughout the body and becomes part of the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells. One of the major known functions of matrix metallopeptidase 2 is to cut (cleave) a protein called type IV collagen. Type IV collagen is a major structural component of basement membranes, which are thin, sheet-like structures that separate and support cells as part of the extracellular matrix.
The activity of matrix metallopeptidase 2 appears to be important for a variety of body functions. These include the breakdown of the uterine lining (endometrium) during menstruation, formation and growth of new blood vessels, repair of damaged tissues, and inflammation. Matrix metallopeptidase 2 also plays a role in bone remodeling, which is a normal process in which old bone is broken down and new bone is created to replace it.
Conditions referring to this gene or chromosome
Other names
72 kDa gelatinase
72 kDa type IV collagenase
CLG4
CLG4A
collagenase type IV-A
gelatinase A
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
matrix metalloproteinase-2
matrix metalloproteinase-II
MMP-2
MMP-II
MMP2_HUMAN
neutrophil gelatinase
TBE-1
Patient picks for Genes

PID Q&A
How do you contract PID?
Dr Sarah Jarvis MBE It is not known how many women develop PID each year, and it is probably often not picked up. It most commonly develops in women aged between 15 and 24 years. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-2)
by Dr Sarah Jarvis

Diabetes Q&A
How do you get tested for type 2 diabetes?
Dr Sarah Jarvis MBE It is now recommended that the blood test for HbA1c can also be used as a test to diagnose type 2 diabetes. An HbA1c value of 48 mmol/mol (6.5%) or above is recommended as the blood level for diagnosing diabetes. In many cases type 2 diabetes is diagnosed during a routine medical or when tests are done for an unrelated medical condition. For more information on type 2 diabetes, go to [https://patient.info/health/type-2-diabetes](https://patient.info/health/type-2-diabetes)
by Dr Sarah Jarvis

Diabetes Q&A
Can you drive if you have diabetes?
Dr Sarah Jarvis MBE Hypos can cause drowsiness, dizziness and confusion: in severe cases they can lead to loss of consciousness or even be fatal. But hypos can also affect your ability to drive safely. So the DVLA has set out guidelines for people with all diabetes - and whether you have type 1 or type 2 diabetes, you need to know about them. For more information on diabetes and driving, go to [https://patient.info/health/diabetes-mellitus-leaflet/driving-and-diabetes](https://patient.info/health/diabetes-mellitus-leaflet/driving-and-diabetes)
by Dr Sarah Jarvis

Type 2 diabetes Q&A
How do you know if you have type 2 diabetes?
Dr Partha Kar Type 2 diabetes symptoms often come on gradually and can be quite vague at first. Many people have diabetes for a long period of time before their diagnosis is made. [https://patient.info/health/type-2-diabetes#nav-2](https://patient.info/health/type-2-diabetes#nav-2)
by Dr Partha Kar, FRCP

Other diabetes
Can athletes get diabetes?
Dr Sarah Jarvis MBE There are two main types of diabetes mellitus, which are called type 1 diabetes and type 2 diabetes. Type 1 usually first presents in children or in young adults. Type 2 is more associated with being overweight and most often first presents in people over the age of 40 years. However, type 2 diabetes is increasingly diagnosed in children and in young adults. For more information on diabetes, go to [https://patient.info/health/diabetes-mellitus-leaflet](https://patient.info/health/diabetes-mellitus-leaflet)
by Dr Sarah Jarvis

Diabetes Q&A
Who is most at risk from developing type 2 diabetes?
Dr Partha Kar The number of people with type 2 diabetes is increasing in the UK, as it is more common in people who are overweight or obese. It also tends to run in families. It is around five times more common in South Asian and African-Caribbean people (often developing before the age of 40 in this group). It is estimated that there are around 940,000 people in England with type 2 diabetes who have not yet been diagnosed with the condition. [https://patient.info/health/type-2-diabetes#nav-1](https://patient.info/health/type-2-diabetes#nav-1)
by Dr Partha Kar, FRCP
Related patient information and medicines

Patient information leaflet
Can I take Iron supplements and Sedoxil together?
Taking iron supplements at the same time as Sedoxil (mexazolam) may reduce how much of the medication your body absorbs. This could make the Sedoxil less effective at treating anxiety or helping you sleep. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take.

Patient information leaflet
Type 2 diabetes treatment
If a high blood sugar level is brought down to a normal level, your symptoms will ease and your risk of long-term complications will be much lower. Managing type 2 diabetes Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. Regardless of whether you need.

Patient information leaflet
Glandular fever
Glandular fe. Although it can make some people feel quite ill, full recovery is usual. What is glandular fever. Glandular fever is a viral infection, mostly caused by the Epstein-Barr virus. The virus can be passed from person to person by close contact. Glandular fever is known as infectious mononucleosis in the US and some other countries. This.

Medicine leaflet
Imatinib tablets
You will ... It is important that you keep the regular appointments with your doctor or hospital. About imatinib Type of medicine A chemotherapy medicine Used for Certain cancers and blood diseases Also called Glivec® Available as Tablets, capsules and oral liquid medicine Imatinib is a medicine which is given to treat some cancers and certain.

Patient information leaflet
5:2 diet
The 5:2 diet is a calorie-restricted diet that involves eating 'normally' for five days out of seven and then 'fasting' on the other two days out of seven. The proposed health effects of the 5:2 diet include weight loss, improvement in life expectancy, protection against certain cancers and protection against dementia. However, the evidence.

Medicine leaflet
Levomepromazine tablets
About levomepromazine Type of medicine An antipsychotic medicine Used for Easing distressing symptoms in palliative care; easing symptoms of schizophrenia Also called Nozinan®, Leverol® Available as Tablets, injection Levomepromazine is sometimes given as an injection to people who are terminally ill to help ease distressing symptoms such as pain,.
Further reading and references
- matrix metallopeptidase 2; MedlinePlus, National Library of Medicine.
- Castberg FC, Kjaergaard S, Mosig RA, Lobl M, Martignetti C, Martignetti JA, Myrup C, Zak M. Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review. Eur J Pediatr. 2013 Dec;172(12):1657-63. doi: 10.1007/s00431-013-2102-8. Epub 2013 Jul 31.
- Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, Glucksman MJ, Bahabri S, Meyer BF, Desnick RJ. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet. 2001 Jul;28(3):261-5. doi: 10.1038/90100.
- Mosig RA, Dowling O, DiFeo A, Ramirez MC, Parker IC, Abe E, Diouri J, Aqeel AA, Wylie JD, Oblander SA, Madri J, Bianco P, Apte SS, Zaidi M, Doty SB, Majeska RJ, Schaffler MB, Martignetti JA. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet. 2007 May 1;16(9):1113-23. doi: 10.1093/hmg/ddm060. Epub 2007 Mar 30.
- Rouzier C, Vanatka R, Bannwarth S, Philip N, Coussement A, Paquis-Flucklinger V, Lambert JC. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet. 2006 Mar;69(3):271-6. doi: 10.1111/j.1399-0004.2006.00584.x.
- Tuysuz B, Mosig R, Altun G, Sancak S, Glucksman MJ, Martignetti JA. A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. Eur J Hum Genet. 2009 May;17(5):565-72. doi: 10.1038/ejhg.2008.204. Epub 2008 Nov 5.
- Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Furga A. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin Genet. 2005 Mar;67(3):261-6. doi: 10.1111/j.1399-0004.2004.00402.x.
- Zankl A, Pachman L, Poznanski A, Bonafe L, Wang F, Shusterman Y, Fishman DA, Superti-Furga A. Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome. J Bone Miner Res. 2007 Feb;22(2):329-33. doi: 10.1359/jbmr.061013.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

